Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2021 Feb 2;60(10):5056–5062. doi: 10.1002/anie.202016164

Metal‐Free Electrochemical Synthesis of Sulfonamides Directly from (Hetero)arenes, SO2, and Amines

Stephan P Blum 1, Tarik Karakaya 1, Dieter Schollmeyer 1, Artis Klapars 2, Siegfried R Waldvogel 1,
PMCID: PMC7985875  PMID: 33372349

Abstract

Sulfonamides are among the most important chemical motifs in pharmaceuticals and agrochemicals. However, there is no methodology to directly introduce the sulfonamide group to a non‐prefunctionalized aromatic compound. Herein, we present the first dehydrogenative electrochemical sulfonamide synthesis protocol by exploiting the inherent reactivity of (hetero)arenes in a highly convergent reaction with SO2 and amines via amidosulfinate intermediate. The amidosulfinate serves a dual role as reactant and supporting electrolyte. Direct anodic oxidation of the aromatic compound triggers the reaction, followed by nucleophilic attack of the amidosulfinate. Boron‐doped diamond (BDD) electrodes and a HFIP–MeCN solvent mixture enable selective formation of the sulfonamides. In total, 36 examples are demonstrated with yields up to 85 %.

Keywords: electrochemistry, green chemistry, oxidation, radical reactions, sulfonamides


A convergent single‐step synthesis of sulfonamides directly from (hetero)arenes, SO2, and amines by electrochemical C−H activation is presented. No prefunctionalization of the aromatic compound is required and halogen substituents are tolerated. The in situ formation of the amidosulfinate species serves a dual role as nucleophile and supporting electrolyte.

graphic file with name ANIE-60-5056-g001.jpg


Sulfonamides exhibit unique antibacterial properties[ 1 , 2 , 3 ] and are classified as “highly important antimicrobials” by WHO. [4] Gerhard Domagk was awarded the Nobel prize in 1939 for introducing them as antibacterial chemotherapeutic agents. [2] Even though sulfonamides rarely occur in nature,[ 5 , 6 , 7 ] it was later on discovered that they reveal numerous other biological activities.[ 8 , 9 ] Anti‐tumoral, [10] anti‐obesity, [11] and anti‐inflammatory[ 8 , 12 ] activity are just a few examples.

The protease inhibitor Fosamprenavir (1) is an anti‐HIV prodrug (Scheme 1).[ 13 , 14 ] Hydrochlorothiazide (2) is used against high blood pressure.[ 14 , 15 ] The vasodilatory drug Sildenafil (3) became well‐known for the treatment of erectile dysfunction[ 14 , 16 ] and Probenecid (4) is a well‐established drug to medicate gout.[ 14 , 17 ] Additionally, sulfonamides are common chemical motifs in agrochemicals,[ 5 , 18 ] plasticizers, [19] dyes/pigments, [20] and polymers. [21] The high chemical and metabolic stability[ 6 , 7 , 22 ] combined with the interesting physicochemical properties [23] makes sulfonamide functionalities highly important in bioactive molecules.[ 3 , 22 ] For this reason, extensive research effort has been put into the development of more efficient syntheses of sulfonamides. [24]

Scheme 1.

Scheme 1

Sulfonamide‐containing drugs.

Traditionally, sulfonamides are directly prepared by reaction of an amine with a sulfonyl chloride (Scheme 2). However, sulfonyl chlorides are moisture‐sensitive [25] and many may not be amenable to long‐term storage. [3] They can be obtained by treatment of chlorosulfuric acid with the corresponding aromatic compound. Harsh reaction conditions and multiple equivalents [26] of the corrosive chlorosulfuric acid are often required and the selectivity is limited to the inherent reactivity of the aromatic compound, which can result in regioisomer mixtures.[ 27 , 28 ] An interesting alternative method was reported by Willis and co‐workers featuring the CuII‐catalyzed synthesis of sulfonamides starting from the corresponding arylboronic acid with DABSO as SO2 source. [6] However, harsh reaction conditions, the cost of DABSO, necessary prefunctionalization of the arene and excess of the boronic acid component are drawbacks in this approach. Just recently, Noël and co‐workers published the electrochemical conversion of thiophenols to sulfonamides in presence of an amine. [7] Despite the convergent nature, this methodology suffers from certain disadvantages, such as the need of a supporting electrolyte. Furthermore, thiophenols are considered air sensitive, toxic and foul‐smelling and only a limited selection is available commercially. [29] In the past decades, numerous other publications dealing with sulfonamide syntheses were reported.[ 3 , 22 , 27 , 30 , 31 ] Once again, all methods are based on prefunctionalized scaffolds. Herein, we present the first one‐step synthesis of sulfonamides, directly from (hetero)arenes, SO2, and amines in a multi‐component reaction via electrochemical C−H activation. [32] An amine and SO2 are proposed to form the amidosulfinate intermediate, which takes a dual role as nucleophile and supporting electrolyte. The feedstock chemical SO2[ 31 , 33 ] is incorporated into the substrate in an atom‐economical way, avoiding the use of expensive SO2 surrogates. Inexpensive electricity serves as “green” oxidant—electrochemical reactions in general are considered sustainable, inherently safe, and scalable.[ 34 , 35 ] BDD electrodes [36] and the solvent 1,1,1,3,3,3‐hexafluoropropan‐2‐ol (HFIP), [37] important to the success of this transformation, enable novel electrochemical reactivity. [38] Moreover, the robustness of such transformations [39] and the long life‐time of BDD electrodes [40] in combination with the possibility of HFIP recovery[ 35 , 41 ] make this approach even more environmentally friendly. Just recently, our group reported the electrochemical synthesis of alkyl arylsulfonates from arenes, alcohols, and SO2 in a multi‐component reaction, [28] and this encouraged us to explore the possibility of a direct electrochemical synthesis of sulfonamides.

Scheme 2.

Scheme 2

Selected strategies for the synthesis of sulfonamides. DABSO=1,4‐diazabicyclo[2.2.2]octane–bis(sulfur dioxide) adduct; DIPEA=N,N‐diisopropylethylamine.

Guided by our previous studies on arylsulfonates, [28] we chose 1,2,3‐trimethoxybenzene as arene model substrate for reaction optimization in combination with morpholine as amine. We were delighted to observe the formation of the desired sulfonamide as two regioisomers 5 a and 5 b in a 6:1 ratio as depicted in Scheme 3. Reaction optimization showed that a 1:1 solvent mixture of HFIP/MeCN was superior (Table 1, entry 1) in comparison to excess HFIP (Table 1, entry 2) or excess MeCN (Table 1, entry 3). HFIP/DMSO (1:1) proved to be unsuitable for this reaction (Table 1, entry 4), whereas HFIP/CH2Cl2 (1:1) gave 57 % combined yield (Table 1, entry 5). Electrolysis in undivided cells resulted in lower product formation (Table 1, entry 6). Slight increase of the SO2 concentration to 1.5 m (Table 1, entry 7) had no significant influence on the reaction. Likewise, the increase to 12 mA cm−2 current density also did not show any remarkable difference (Table 1, entry 8). The modulation of the applied amount of charge to 3.5 F increased the yield to 72 % (Table 1, entry 9), though 5.5 F resulted in less product formation due to overoxidation of the sulfonamide (Table 1, entry 10). Omitting of DIPEA decreased the yield and resulted in lower conductivity of the electrolyte (Table 1, entry 11). Graphite and platinum electrodes (Table 1, entries 12 and 13) provided worse results, but it is noteworthy that glassy carbon showed similar reactivity compared to BDD electrodes (Table 1, entry 14). No product was found when the electricity was omitted (Table 1, entry 15). Finally, the conditions from Table 1, entry 9 were chosen for further reactions.

Scheme 3.

Scheme 3

General reaction scheme for the electrochemical synthesis of sulfonamides during the optimization process. [a] The 6:1 regioisomeric ratio was determined according to the crude NMR of entry 9 (Table 1).

Table 1.

Optimization reactions of the model substrates.

Entry

Deviation from the standard conditions[a]

Yield [%][b]

1

none

54

2

HFIP/MeCN (9:1)

39

3

HFIP/MeCN (1:9)

traces

4

HFIP/DMSO (1:1)

traces

5

HFIP/CH2Cl2 (1:1)

57

6

undivided cell

13

7

1.5 m SO2

53

8

1.5 m SO2, 12 mA cm−2

55

9

1.5 m SO2, 12 mA cm−2, 3.5 F

72

10

1.5 m SO2, 12 mA cm−2, 5.5 F

40

11

1.5 m SO2, 12 mA cm−2, 3.5 F, no DIPEA

31

12

1.5 m SO2, 12 mA cm−2, 3.5 F,

Pt electrodes

59

13

1.5 m SO2, 12 mA cm−2, 3.5 F,

graphite electrodes

49

14

1.5 m SO2, 12 mA cm−2, 3.5 F

glassy carbon electrodes

72

15

1.5 m SO2, no electricity

0

[a] Standard conditions: 1,2,3‐trimethoxybenzene (0.6 mmol, 0.1 m), morpholine (3 eq.), DIPEA (4 eq.), SO2 (1.2 m), HFIP/MeCN=1:1 (vol %), r.t., divided cell (glass frit), BDD electrodes, j=7 mA cm−2, Q=2.5 F. [b] Combined yield of 5 a and 5 b determined by internal NMR standard (1,3,5‐trimethoxybenzene); DMSO=dimethylsulfoxide.

After completion of the optimization process, the substrate scope was expanded in regard to different arenes in combination with morpholine (Scheme 4). Amazingly, sulfonamide 6 was isolated in 80 % yield. Remarkably, bromo, chloro, fluoro, and iodo substituents were tolerated in 7 a/7 b12, which provides an opportunity for further functionalization via metal‐catalyzed coupling reactions. [42] The sulfonamide derivatives (13 a/13 b) of veratrole were obtained in 79 % combined yield.

Scheme 4.

Scheme 4

Sulfonamide substrate scope of different (hetero)arenes. Grey background: isolated regioisomers. [a] Reaction conditions: arene substrate (0.6 mmol, 0.1 m), morpholine (3 equiv.), DIPEA (4 equiv.), SO2 (1.5 m), HFIP/MeCN=1:1, divided cell (glass frit), r.t., BDD electrodes, j=12 mA cm−2, Q=3.5 F.

Two further regioisomers with roughly the same ratio were formed with 2‐methyl‐1,4‐dimethoxybenzene as starting material, giving 14 a/14 b in 61 % combined yield and anisole derivatives 15 a/15 b were obtained in 31 % yield. The sulfonamides 16 (37 %) and 17 (34 %) were in similar yield range, whereas benzodioxane derivatives 18 a/18 b gave 79 %. Thiophene‐derived heterocyclic structure 19 only provided 11 % yield and benzodioxole derivative 20 gave 42 %. Further halogen‐containing benzodioxoles provided lower yields (21, 26 %; 22, 25 %). Finally, two natural products (methyleugenol and safrol) containing potentially sensitive alkene functionality were successfully converted to their sulfonamide derivative (23, 23 %; 24, 16 %). In general, less electron‐rich arenes were ineligible for this reaction.

Thereupon, the amine substrate scope was investigated by using 1,4‐dimethoxybenzene as arene substrate (Scheme 5). Several secondary amines were implemented, such as diisobutylamine, which provided sulfonamide 25 (63 %). Comparable yields ranging from 52–56 % (26, 56 %; 27, 55 %; 28, 52 %) were achieved with azepine, 2‐methylpiperidine, and tetrahydroisoquinoline. Dipropylamine and pyrrolidine provided slightly lower yields (29, 39 %; 30, 37 %). Primary amines in general suffered from poor conversion. However, benzylamine derivative 31 was isolated in 29 % yield. Sulfonamide 32 with l‐proline methyl ester hydrochloride as amine substrate was obtained in 24 % yield (the lower yield is potentially due to precipitation of the amine–SO2 complex in the electrolyte). A list of substrates that were tried can be retrieved from the Supporting Information.

Scheme 5.

Scheme 5

Sulfonamide substrate scope of different amines. [a] Reaction conditions: 1,4‐dimethoxybenzene (0.6 mmol, 0.1 m), amine substrate (3 equiv.), DIPEA (4 equiv.), SO2 (1.5 m), HFIP/MeCN=1:1, divided cell (glass frit), r.t., BDD electrodes, j=12 mA cm−2, Q=3.5 F; [b] l‐proline methyl ester hydrochloride (3 equiv.) and DIPEA (5 equiv.) were used.

Next, the scalability of the reaction was investigated. A simple H‐type glass cell, divided by a glass frit (Scheme 6), was used for this purpose. The synthesis of 6 was scaled up from 0.6 mmol to 8.0 mmol (13‐fold increase). To our delight, the yield of this reaction increased to 85 % in this scale‐up reaction with 1.95 g isolated product.

Scheme 6.

Scheme 6

Scale‐up reaction. Comparison between screening cell (normal scale) and H‐type glass cell (scale‐up reaction).

Finally, the reaction mechanism was considered. Sulfur dioxide and the amine form Lewis acid–base adducts, generating amidosulfinates in an equilibrium reaction after deprotonation by an organic base (Scheme 7). Likewise, Willis and co‐workers considered this species as nucleophile in their studies (Scheme 2). [6] The formation of an amine–SO2 complex is well described in the literature. [43] However, complexes of triethylamine or DIPEA with SO2 are relatively unstable.[ 31 , 44 ] Furthermore, the presence of HFIP could weaken the S−N interaction, so that DIPEA takes the role as base in this reaction also leading to deprotonation of HFIP, which is considered as additional supporting electrolyte [45] and protonation probably also minimizes competitive oxidation of DIPEA. In general, sterically hindered amine substrates with weaker S−N interaction, such as dibenzylamine or 2,2,6,6‐tetramethylpiperidine, did not perform well in this reaction. We conclude that only amines with stronger dative bonds to SO2 are eligible for this protocol.

Scheme 7.

Scheme 7

Postulated reaction mechanism.

The proposed mechanism of the electrochemical sulfonamide synthesis proceeds via initial anodic oxidation of the arene substrate to form the radical cation intermediate (Scheme 7). Subsequent nucleophilic attack of the amidosulfinate, followed by a second oxidation step, provides the sulfonamide. As cathodic reaction, SO2 reduction was identified in our previous work. [28] Therefore, undivided cells are ineligible due to anodic reoxidation of the reduced SO2 species resulting in significant lower overall current efficiency.

Additionally, cyclic voltammetry studies were executed in order to support the proposal of the reaction mechanism (Scheme 8). The oxidation potentials of 1,4‐dimethoxybenzene (1.05 V) and 1,2,3‐trimethoxybenzene (1.13 V) indicate the initial anodic oxidation of the arene substrate when comparing to the amidosulfinate species (black graph), which determines the electrochemical potential window. The increased oxidation potential of 6 (1.26 V) in comparison to 1,4‐dimethoxybenzene is in accordance with the electron‐withdrawing sulfonamide substituent.

Scheme 8.

Scheme 8

Cyclic voltammetry results. Black graph: morpholine (0.3 m), DIPEA (0.4 m), SO2 (1.5 m), HFIP/MeCN=1:1.

In conclusion, we have developed the first single‐step dehydrogenative synthesis of sulfonamides from non‐prefunctionalized electron‐rich (hetero)arenes, SO2, and amines. Highlights of this reaction are the use of inexpensive electricity as “green” oxidant, as well as no necessity of any additional supporting electrolyte. In situ formed amidosulfinates perform a dual role as nucleophile and electrolyte. The direct use of SO2 from a stock solution increases the atom economy of this reaction in comparison to expensive SO2 surrogates such as DABSO. Regarding the mechanism of the reaction, direct anodic oxidation of the (hetero)arene is proposed to initiate the reaction based on the CV data. In total, 36 different products were isolated, showing the full potential of this novel reaction. Importantly, fluoro, chloro, bromo, and iodo substituents are tolerated providing complementarity to transition metal‐catalyzed reactions. Scalability of the reaction has been demonstrated by a 13‐fold scale‐up.

Conflict of interest

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary

Acknowledgements

The Carl Zeiss Stiftung is gratefully acknowledged for the electrosynthesis network ELYSION. Financial support by Deutsche Forschungsgemeinschaft (DFG: Wa1276/17‐2) is highly appreciated. S. Blum thanks Nicole Ehler for RP‐HPLC separation of regioisomers. Open access funding enabled and organized by Projekt DEAL.

S. P. Blum, T. Karakaya, D. Schollmeyer, A. Klapars, S. R. Waldvogel, Angew. Chem. Int. Ed. 2021, 60, 5056.

In memory of François Diederich

References

  • 1. Tačić A., Nikolić V., Nikolić L., Savic I., Adv. Technol. 2017, 6, 58–71. [Google Scholar]
  • 2. Otten H., J. Antimicrob. Chemother. 1986, 17, 689–690. [DOI] [PubMed] [Google Scholar]
  • 3. Caddick S., Wilden J. D., Judd D. B., J. Am. Chem. Soc. 2004, 126, 1024–1025. [DOI] [PubMed] [Google Scholar]
  • 4. Critically Important Antimicrobials for Human Medicine, 6th revision, World Health Organization, Geneva, 2019. Licence: CC BY-NC-SA 3.0 IGO. [Google Scholar]
  • 5. Caine B. A., Bronzato M., Popelier P. L. A., Chem. Sci. 2019, 10, 6368–6381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Chen Y., Murray P. R. D., Davies A. T., Willis M. C., J. Am. Chem. Soc. 2018, 140, 8781–8787. [DOI] [PubMed] [Google Scholar]
  • 7. Laudadio G., Barmpoutsis E., Schotten C., Struik L., Govaerts S., Browne D. L., Noël T., J. Am. Chem. Soc. 2019, 141, 5664–5668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Supuran C. T., Molecules 2017, 22, 1642. [Google Scholar]
  • 9. Bhat M. A., Imran M., Khan S. A., Siddiqui N., Indian J. Pharm. Sci. 2005, 67, 151–159. [Google Scholar]
  • 10. Dai X., Kaluz S., Jiang Y., Shi L., Mckinley D., Wang Y., Wang B., van Meir E. G., Tan C., Oncotarget 2017, 8, 99245–99260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. 
  • 11a. De Simone G., Supuran C. T., Curr. Top. Med. Chem. 2007, 7, 879–884; [DOI] [PubMed] [Google Scholar]
  • 11b. al-Rashida M., Hussain S., Hamayoun M., Altaf A., Iqbal J., Di Fiore A., Biomed. Res. Int. 2014, 2014, 162928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Shoaib Ahmad Shah S., Rivera G., Ashfaq M., Mini-Rev. Med. Chem. 2012, 13, 70–86. [PubMed] [Google Scholar]
  • 13. Ellis J. M., Ross J. W., Coleman C. I., Formulary 2004, 39, 151. [Google Scholar]
  • 14. Wishart D. S., Feunang Y. D., Guo A. C., Lo E. J., Marcu A., Grant J. R., Sajed T., Johnson D., Li C., Sayeeda Z., et al., Nucleic Acids Res. 2018, 46, D1074-D1082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Roush G. C., Holford T. R., Guddati A. K., Hypertension 2012, 59, 1110–1117. [DOI] [PubMed] [Google Scholar]
  • 16. Goldstein I., Lue T. F., Padma-Nathan H., Rosen R. C., Steers W. D., Wicker P. A., N. Engl. J. Med. 1998, 338, 1397–1404. [DOI] [PubMed] [Google Scholar]
  • 17. Silverman W., Locovei S., Dahl G., Am. J. Physiol. Cell Physiol. 2008, 295, C761–C767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. 
  • 18a. Devendar P., Yang G.-F., Topics Curr. Chem. 2017, 375, 82; [DOI] [PubMed] [Google Scholar]
  • 18b. Clemens L., J. Sulfur Chem. 2004, 25, 39–62. [Google Scholar]
  • 19. 
  • 19a. de Groote P., Rouxhet P. G., Devaux J., Godard P., Appl. Spectrosc. 2001, 55, 877–887; [Google Scholar]
  • 19b. de Groote P., Devaux J., Godard P., J. Polym. Sci. Part B 2002, 40, 2208–2218; [Google Scholar]
  • 19c. Aelony D., Ind. Eng. Chem. Res. 1954, 46, 587–591. [Google Scholar]
  • 20. 
  • 20a. Wang L., Pan X., Wang F., Yang L., Liu L., Dyes Pigm. 2008, 76, 636–645; [Google Scholar]
  • 20b. Gaffer H. E., Elgohary M. R., Etman H. A., Shaaban S., Pigment Resin Technol. 2017, 46, 210–217. [Google Scholar]
  • 21. 
  • 21a. Kang S. I., Bae Y. H., J. Controlled Release 2002, 80, 145–155; [DOI] [PubMed] [Google Scholar]
  • 21b. Chan W.-H., Lam-Leung S. Y., Ng C.-F., Ding J., Xi S., Polymer 1995, 36, 4503–4508. [Google Scholar]
  • 22. Ashfaq M., Shah S. S. A., Najam T., Shaheen S., Rivera G., Mini-Rev. Med. Chem. 2013, 13, 160–170. [Google Scholar]
  • 23. Soriano-Correa C., Esquivel R., Sagar R., Int. J. Quantum Chem. 2003, 94, 165–172. [Google Scholar]
  • 24. Gómez-Palomino A., Cornella J., Angew. Chem. Int. Ed. 2019, 58, 18235–18239; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 18403–18407. [Google Scholar]
  • 25. Fu Y., Zhu W., Zhao X., Hügel H., Wu Z., Su Y., Du Z., Huang D., Hu Y., Org. Biomol. Chem. 2014, 12, 4295–4299. [DOI] [PubMed] [Google Scholar]
  • 26. Janosik T., Shirani H., Wahlström N., Malky I., Stensland B., Bergman J., Tetrahedron 2006, 62, 1699–1707. [Google Scholar]
  • 27. Pandya R., Murashima T., Tedeschi L., Barrett A. G. M., J. Org. Chem. 2003, 68, 8274–8276. [DOI] [PubMed] [Google Scholar]
  • 28. Blum S. P., Schollmeyer D., Turks M., Waldvogel S. R., Chem. Eur. J. 2020, 26, 8358–8362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Magné V., Ball L. T., Chem. Eur. J. 2019, 25, 8903–8910. [DOI] [PubMed] [Google Scholar]
  • 30. 
  • 30a. Bahrami K., Khodaei M. M., Soheilizad M., J. Org. Chem. 2009, 74, 9287–9291; [DOI] [PubMed] [Google Scholar]
  • 30b. Chung Leung G. Y., Ramalingam B., Loh G., Chen A., Org. Process Res. Dev. 2020, 24, 546–554; [Google Scholar]
  • 30c. Deng X., Mani N. S., Green Chem. 2006, 8, 835–838; [Google Scholar]
  • 30d. Eid N., Karamé I., Andrioletti B., Eur. J. Org. Chem. 2018, 5016–5022; [Google Scholar]
  • 30e. Flegeau E., Harrison J., Willis M., Synlett 2015, 27, 101–105; [Google Scholar]
  • 30f. Liu T., Zheng D., Li Z., Wu J., Adv. Synth. Catal. 2017, 359, 2653–2659; [Google Scholar]
  • 30g. Moon S.-Y., Nam J., Rathwell K., Kim W.-S., Org. Lett. 2014, 16, 338–341; [DOI] [PubMed] [Google Scholar]
  • 30h. Mukherjee P., Woroch C. P., Cleary L., Rusznak M., Franzese R. W., Reese M. R., Tucker J. W., Humphrey J. M., Etuk S. M., Kwan S. C., et al., Org. Lett. 2018, 20, 3943–3947; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30i. Shyam P. K., Jang H.-Y., J. Org. Chem. 2017, 82, 1761–1767; [DOI] [PubMed] [Google Scholar]
  • 30j. Woolven H., González-Rodríguez C., Marco I., Thompson A. L., Willis M. C., Org. Lett. 2011, 13, 4876–4878; [DOI] [PubMed] [Google Scholar]
  • 30k. Zhang F., Zheng D., Lai L., Cheng J., Sun J., Wu J., Org. Lett. 2018, 20, 1167–1170; [DOI] [PubMed] [Google Scholar]
  • 30l. Zhang W., Xie J., Rao B., Luo M., J. Org. Chem. 2015, 80, 3504–3511; [DOI] [PubMed] [Google Scholar]
  • 30m. Alvarez E. M., Plutschack M. B., Berger F., Ritter T., Org. Lett. 2020, 22, 4593–4596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Emmett E. J., Willis M. C., Asian J. Org. Chem. 2015, 4, 602–611. [Google Scholar]
  • 32. 
  • 32a. Kärkäs M. D., Chem. Soc. Rev. 2018, 47, 5786–5865; [DOI] [PubMed] [Google Scholar]
  • 32b. Sauermann N., Meyer T. H., Qiu Y., Ackermann L., ACS Catal. 2018, 8, 7086–7103. [Google Scholar]
  • 33. 
  • 33a. Vogel P., Turks M., Bouchez L., Marković D., Varela-Álvarez A., Sordo J. Á., Acc. Chem. Res. 2007, 40, 931–942; [DOI] [PubMed] [Google Scholar]
  • 33b. Willis M. C., Phosphorus Sulfur Silicon Relat. Elem. 2019, 194, 654–657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. 
  • 34a. Möhle S., Zirbes M., Rodrigo E., Gieshoff T., Wiebe A., Waldvogel S. R., Angew. Chem. Int. Ed. 2018, 57, 6018–6041; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 6124–6149; [Google Scholar]
  • 34b. Wiebe A., Gieshoff T., Möhle S., Rodrigo E., Zirbes M., Waldvogel S. R., Angew. Chem. Int. Ed. 2018, 57, 5594–5619; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 5694–5721. [Google Scholar]
  • 35. Röckl J. L., Pollok D., Franke R., Waldvogel S. R., Acc. Chem. Res. 2020, 53, 45–61. [DOI] [PubMed] [Google Scholar]
  • 36. 
  • 36a. Gleede B., Yamamoto T., Nakahara K., Botz A., Graßl T., Neuber R., Matthée T., Einaga Y., Schuhmann W., Waldvogel S. R., ChemElectroChem 2019, 6, 2771–2776; [Google Scholar]
  • 36b. Lips S., Waldvogel S. R., ChemElectroChem 2019, 6, 1649–1660. [Google Scholar]
  • 37. 
  • 37a. Elsler B., Schollmeyer D., Dyballa K. M., Franke R., Waldvogel S. R., Angew. Chem. Int. Ed. 2014, 53, 5210–5213; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2014, 126, 5311–5314; [Google Scholar]
  • 37b. Schulz L., Waldvogel S. R., Synlett 2019, 30, 275–286. [Google Scholar]
  • 38. 
  • 38a. Beil S. B., Müller T., Sillart S. B., Franzmann P., Bomm A., Holtkamp M., Karst U., Schade W., Waldvogel S. R., Angew. Chem. Int. Ed. 2018, 57, 2450–2454; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 2475–2479; [Google Scholar]
  • 38b. Gieshoff T., Kehl A., Schollmeyer D., Moeller K. D., Waldvogel S. R., J. Am. Chem. Soc. 2017, 139, 12317–12324; [DOI] [PubMed] [Google Scholar]
  • 38c. Imada Y., Röckl J. L., Wiebe A., Gieshoff T., Schollmeyer D., Chiba K., Franke R., Waldvogel S. R., Angew. Chem. Int. Ed. 2018, 57, 12136–12140; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 12312–12317; [Google Scholar]
  • 38d. Lips S., Schollmeyer D., Franke R., Waldvogel S. R., Angew. Chem. Int. Ed. 2018, 57, 13325–13329; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 13509–13513; [Google Scholar]
  • 38e. Rodrigo E., Waldvogel S. R., Chem. Sci. 2019, 10, 2044–2047; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38f. Schulz L., Enders M., Elsler B., Schollmeyer D., Dyballa K. M., Franke R., Waldvogel S. R., Angew. Chem. Int. Ed. 2017, 56, 4877–4881; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 4955–4959; [Google Scholar]
  • 38g. Waldvogel S. R., Möhle S., Angew. Chem. Int. Ed. 2015, 54, 6398–6399; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2015, 127, 6496–6497; [Google Scholar]
  • 38h. Wiebe A., Lips S., Schollmeyer D., Franke R., Waldvogel S. R., Angew. Chem. Int. Ed. 2017, 56, 14727–14731; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 14920–14925. [Google Scholar]
  • 39. 
  • 39a. Wiebe A., Riehl B., Lips S., Franke R., Waldvogel S. R., Sci. Adv. 2017, 3, eaao3920; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39b. Waldvogel S. R., Lips S., Selt M., Riehl B., Kampf C. J., Chem. Rev. 2018, 118, 6706–6765. [DOI] [PubMed] [Google Scholar]
  • 40. 
  • 40a. Freitas J. M., Oliveira T. d. C., Munoz R. A. A., Richter E. M., Front. Chem. 2019, 7, 190; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40b. Waldvogel S. R., Mentizi S., Kirste A. in Radicals in Synthesis III (Eds.: Heinrich M., Gansäuer A.), Springer, Berlin, Heidelberg, 2012, pp. 1–31. [Google Scholar]
  • 41. Sinha S. K., Bhattacharya T., Maiti D., React. Chem. Eng. 2019, 4, 244–253. [Google Scholar]
  • 42. Biffis A., Centomo P., Del Zotto A., Zecca M., Chem. Rev. 2018, 118, 2249–2295. [DOI] [PubMed] [Google Scholar]
  • 43. 
  • 43a. Ando R., Matazo D., Santos P., J. Raman Spectrosc. 2010, 41, 771–775; [Google Scholar]
  • 43b. Blaschette A., Safari H., Z. Naturforsch. B 1970, 25, 319–320; [Google Scholar]
  • 43c. Faria D. L. A., Santos P. S., J. Raman Spectrosc. 1988, 19, 471–478; [Google Scholar]
  • 43d. Shim J.-G., Jhon Y. H., Kim J. H., Jang K.-R., Kim J., Bull. Korean Chem. Soc. 2007, 28, 1609–1612; [Google Scholar]
  • 43e. Monezi N. M., Borin A. C., Santos P. S., Ando R. A., Spectrochim. Acta Part A 2017, 173, 462–467; [DOI] [PubMed] [Google Scholar]
  • 43f. Oh J. J., Hillig K. W., Kuczkowski R. L., J. Phys. Chem. 1991, 95, 7211–7216; [Google Scholar]
  • 43g. Oh J. J., LaBarge M. S., Matos J., Kampf J. W., Hillig K. W., Kuczkowski R. L., J. Am. Chem. Soc. 1991, 113, 4732–4738. [Google Scholar]
  • 44. Eugene F., Langlois B., Laurent E., Phosphorus Sulfur Relat. Elem. 1993, 74, 377–378. [Google Scholar]
  • 45. Röckl J. L., Dörr M., Waldvogel S. R., ChemElectroChem 2020, 7, 3686–3694. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES